Skip to content
Longterm Wiki
All Source Checks
Grant

Grant: ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing (Advanced Research and Invention Agency (ARIA) -> University of Birmingham)

partial50% confidence

2 evidence checks from 1 unique source

Last checked: 4/3/2026

[deterministic-row-match] Partial deterministic match: grantee matched but name did not (48 rows)

Evidence — 1 source, 2 checks

partial50%deterministic-row-match · 4/3/2026
Found: Matched row: {"grantee":"Hashberg Ltd / University of Birmingham","focusArea":"TA1.1","name":"Hyper-optimised Tensor Contraction for Neural Networks Verification","description":"Hashberg Ltd / Univers

Note: [deterministic-row-match] Partial deterministic match: grantee matched but name did not (48 rows)

partial75%Haiku 4.5 · 3/25/2026
Found: The source confirms the existence of 'TA3' (Technical Area 3) within the 'Safeguarded AI' programme, but indicates that TA3 Phase 2 solicitation will NOT proceed as planned. The source states 'All exi

Note: The record claims a grant titled 'ARIA TA3: Safeguarded AI-Enabled Biopharmaceutical Manufacturing' dated 2024-01. The source confirms TA3 exists within Safeguarded AI, but the source text explicitly states the programme is 'pivoting' away from TA3 Phase 2 and that current TA3 Phase 1 projects will continue. The source does not mention 'biopharmaceutical manufacturing' specifically as a TA3 focus. The source also does not provide the specific grant identifiers (XqjV4mbMXQ, bEVAImWDe3) or confirm a January 2024 date for this specific grant. The record appears to reference a specific grant that is not detailed in this source excerpt.

Debug info

Record type: grant

Record ID: 9gNOmiXmUY